spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CIDP Showcases Full Suite of Services at in-cosmetics North America 2017

CIDP (Centre International de Développement Pharmaceutique)

Independent CRO Adds Ex Vivo Model to its Claims Substantiation Protocols

Mauritius, 29 September 2017 – CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), will bring its full suite of services – comprising research activities, in vitro and ex vivo testing, analytical chemistry, formulation, and clinical research – to in-cosmetics North America 2017. CIDP will also present its innovative anti-pollution and blue light study protocols, and reveal a new ex vivo model at the show.

Earlier this year, CIDP unveiled its innovative study protocol for substantiating anti-pollution claims on cosmetic products. Since then, the company has developed an ex vivo model as an addition to its anti-pollution and blue light claim substantiation protocols. This new model allows experiments to be conducted in conditions close to the in vivo model.

The ex vivo model of viable full-thickness skin explants reproduces the same mechanisms that are activated in the different cell layers of the human skin, enabling CIDP researchers to closely monitor the effects of pollution on the skin.

On 11 October at 11:10am, Mrs Véronique NEWTON, Preclinical Laboratory Manager at CIDP, will present the company’s standard protocols for objective substantiation of anti-pollution claims. She will also share more about CIDP’s successful creation of an ex vivo model that mimics in vivo conditions.

“CIDP aims to be the ideal partner to cosmetic manufacturers for their research needs,” commented Mr Jean-Louis ROULE, CEO of CIDP. “Our anti-pollution and blue light protocols had been well-received in Europe, and we’re excited to introduce our ex vivo protocol at in-cosmetics North America this year. The United States is an important market for CIDP, and we’re looking to build on our success in Europe, and strengthen our international strategy by establishing our presence here.”

Visitors can learn more about CIDP’s study protocols and full suite of services at Stand B1.

For more information, please visit www.cidp-cro.com.



phone +230 401 2600
email info@cidp-cro.com
web www.cidp-cro.com/
email BioPark Mauritius, Socota Phoenicia, Sayed Hossen Road, Phoenix 73408, Mauritius
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Automated testing of pharmaceutical packaging

Test-result reproducibility and traceability are essential when testing pharmaceutical packaging and medical products. Zwick has developed a robotic testing system for automated testing applications ranging from childproof bottles (withpress-and-turn caps) to auto-injectors and insulin pens; tests on these include determination of the release force. As well as increasing specimen throughput and reducing per-specimen costs, automation reduces operator influence, while releasing laboratory staff for more demanding activities in line with their skills and qualifications.
More info >>


White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)


More info >>

Industry Events

BIO-Europe 2018-24th Annual International Partnering Conference

5-7 November 2018, Bella Center Copenhagen, Denmark

The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement